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Background: Regular follow-up and monitoring of intraductal papillary mucinous neoplasms (IPMN) is
important as there is a risk of recurrence in both the non-invasive and invasive IPMN.
Methods: Three patients developed pancreatic remnant recurrence after a pancreatico-duodenectomy
for IPMN. Pancreatico-gastrostomy anastomosis was performed in all patients. Long-term follow-up was
performed with radiographical surveillance and by endoscopic gastroscopy.
Results: Magnetic resonance imaging (MRI) and endoscopic ultrasonography (EUS) revealed in one
patient, 2 years after surgery, a 3-cm mass at the site of the anastomosis and dilatation of the Wirsung
duct >6 mm in two other patients (2 and 3 years after surgery, respectively). The diagnosis of recurrence
was confirmed endoscopically by the presence of a large amount of mucin at the anastomotic site.
Cytological examination revealed moderate dysplasia. Opacification of the Wirsung duct after endoscopic
retrograde cholangiopancreatography (ERCP) was only possible in one patient in whom an irregular
stenosis of the duct was observed.
Conclusions: Long-term follow-up of the pancreatic remnant after pancreato-duodenectomy for IPMN
is better achieved with pancreatico-gastrostomy anastomosis.
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Introduction
For intraductal papillary mucinous tumours (IPMN) which dif-
fusely involves the whole pancreas, a total pancreatectomy
should be performed. For localized IPMN, the question of
whether the extent of resection should be partial or complete
remains controversial. The time of recurrence has been reported
to range from 6 months or less than 11 years after the primary
resection.1–9 Even after a partial pancreatectomy with a negative
surgical margin for non-invasive IPMN, the tumour can recur as
disseminated disease or as locally invasive or non-invasive
disease in the pancreatic remnant. For non-invasive IPMN, the
reported overall disease recurrence rate is 1.3–9.3%, with a pan-
creatic remnant recurrence rate of 1.3–6.3% and a disseminated
disease recurrence rate of less than 4.7%.4–8 For invasive IPMN,
the overall disease recurrence rate is 12–68%.4–8 However,
recurrence in the form of disseminated disease (3.4–44%) is
higher than isolated pancreatic remnant recurrence of less than
15%.4–8
Regular follow-up and monitoring of disease recurrence is
important as there is a risk of recurrence in both the non-invasive
and invasive IPMN.9 It has been suggested that pancreatico-gastric
anastomosis should be used after a pancreatico-duodenectomy
(PD) to allow disease surveillance with endoscopy and the sam-
pling of pancreatic juice for cytology.10,11
In the present study, three patients, after a PD for IPMN,
developed isolated pancreatic remnant recurrence. The
pancreatico-gastric anastomosis after gastric partition12 per-
formed in these patients allowed confirmation of the diagnosis
of recurrence and facilitated a completion pancreatectomy.
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Methods
From January 2000 to December 2010, 88 patients with IPMN
were operated on in our department. The most frequent location
was the pancreatic head (53%). The mean imaging size was
32 mm. In all, 23% of the tumours were malignant, 30% were
carcinoma in situ and 70% were invasive. After surgical manage-
ment, a great deal attention was paid during the follow-up period
to detect tumour recurrence.
Three patients, two women (75 and 60 years old, respectively)
and one man (60 years old) underwent pylorus-preserving PD for
branch-duct type IPMN. A final pathological diagnosis was
benign in one patient and invasive IPMN and carcinoma in situ in
the two remaining patients. In all three patients, the remnant of
the pancreas was anastomozed to the stomach after a gastric par-
tition.12 Frozen section examination was reported to be negative in
two patients and mucinous epithelium in one patient.
Results
All three patients had long-term follow-up with clinical, bio-
chemical and radiological assessment. Two years after surgery in
one patient, magnetic resonance cholangiopancreatography
revealed a 3-cm mass in the area of the pancreatico-gastrostomy
and dilatation >6 mm of the Wirsung duct in the other patients.
An endoscopic ultrasonography (EUS) showed in two patients (2
and 3 years after surgery, respectively) an irregular outline of the
dilated duct suggestive of a intraductal polypoid tumour of the
remnant pancreas. Endoscopy revealed a large amount of mucin
oozing from the anastomotic site. Cytological examination
revealed moderate cellular dysplasia. Opacification of the Wirsung
duct after endoscopic retrograde Wirsungraphy was only possible
in one patient and showed an irregular stenosis of the duct.
A completion pancreatectomy was performed in all three
patients. The segment of the stomach involved in the pancreat-
icogastrostomy anastomosis was transected with a stapling
device, 2 cm from the wall of the antrum, and resected en-block
with the remnant of the pancreas (Figs 1 and 2). A spleen-
preserving distal pancreatectomy was performed in one patient
and a distal pancreatectomy and splenectomy in two other
patients. There were no post-operative complications and hos-
pital stay was 8, 9 and 10 days. One patient with invasive IPMN
and nodal involvement died at 2 years with local and distant
metastasis. Final pathological diagnosis in the two other patients
was benign adenoma, and at present these patients are alive 27
and 26 months after surgery.
Discussion
A repeated resection for isolated recurrence in the pancreatic
remnant gives good results.13 Sohn14 et al. reported five patients
with isolated recurrent IPMN in the pancreatic remnant and were
treated with a repeated pancreatectomy. Two patients had non-
Figure 1 The segment of the stomach involved in the pancreatico-gastrostomy anastomosis is transected with a stapling device 2 cm from
the wall of the antrum The completion of pancreatectomy is performed with en-block resection of the segment of the stomach involved in
the pancreatico-gastrostomy anastomosis with the distal pancreas
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invasive IPMN recurrence and three patients had invasive IPMN
recurrence; only one patient died of disseminated disease and the
others were alive without disease. Salvia15 et al. reported six
patients with isolated recurrent IPMN in the pancreatic remnant
and were treated with a repeated pancreatectomy. One patient had
non-invasive IPMN recurrence and five patients had invasive
IPMN recurrence; only three patients died of disseminated
disease. White16 et al. have reported a recurrence rate in a group of
78 patients who underwent resection for non-invasive IPMN. At a
median follow-up of 40 months, six patients had local recurrence
with a median interval of 22 months (range 8 to 62 months). One
of the 50 patients (2%) with margins negative for IPMN had
recurrence compared with 4 out of 23 patients (17%) with posi-
tive margins for IPMN. It has been suggested that as the follow-up
of the pancreatic remnant after resection for IPMN increases, new
lesions will constantly appear regardless of negative surgical
margins at initial resection.
Radiographical surveillance to detect IPMN recurrences may
be difficult as a consequence of post-resection changes in the
remnant gland after a PD. Christensen17 et al. classified the com-
puted tomography (CT) patterns of intrapancreatic recurrence
after resection of IPMN into two types: cystic lesions resembling
a branch-duct tumour and dilatation of the main pancreatic
duct. However, dilatation of the pancreatic duct should not be
only considered diagnostic of recurrence. PD renders the pan-
creas less accessible to EUS and ERCP, which are useful in evalu-
ating ductal abnormalities. The use of pancreaticogastric
anastomosis after PD in patients with IPMN has been reported
previously.10,11,18 In the conventional pancreatico-gastrostomy
technique, the pancreas is invaginated or telescoped in the
stomach. According to Gigot10 and colleagues, this reconstructive
technique permits direct access to the pancreatic stump by endo-
scopy during long-term follow-up, allowing direct opacification
of the pancreatic duct and sampling of the pancreatic juice for
cytological examination. However, cannulation of the Wirsung
duct may be difficult in cases of severe stenosis of the
pancreatico-gastrostomy anastomosis as a result of chronic
inflammation or occlusion of the opening of the pancreatic duct
by IPMN recurrence. In addition, the close proximity of the pan-
creatic remnant with the stomach allows precise EUS examina-
tion of the pancreatic ductal system, as well as a fine-needle
aspiration biopsy.
In our technique of pancreatico-gastrostomy anastomosis, the
remnant of the pancreas is anastomozed to a segment of the
stomach after gastric partition.12 The potential advantage of this
technique over other techniques of pancreatico-gastrostomy anas-
tomosis is that the segment of the stomach involved in the anas-
tomosis does not participate in the passage of food to the bowel.
The potential disadvantage is that access to the pancreatic
remnant may be difficult to the endoscopist in the presence of
severe chronic inflammation and stenosis at the entry of the
segment of the stomach involved in the anastomosis. A comple-
tion pancreatectomy is easily performed with en-block resection
of the segment of the stomach with the distal pancreas, without
altering the rest of the stomach.
In addition to radiographical surveillance, long-term follow-up
of the pancreatic remnant after PD for IPMN is better achieved
with pancreatico-gastrostomy anastomosis. This form of recon-
structive technique allows EUS diagnosis of recurrence, the find-
ings of mucin at the anastomotic site and a pancreatogram to
discover ductal abnormalities with ERCP. A completion pancre-
atectomy is also facilitated when pancreatico-gastrostomy anasto-
mosis is performed after gastric partition.
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Figure 2 Operative view of the transection of the segment of the stomach (created after gastric partition) where the left pancreas was
anastomozed
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